GLP-1 RA Endikasyonlar ve Etkinlii Fazla kilolu ve obeziteli bireylerde kilo kayb salayan tedavi seeneklerinin (rnein orlistat, fentermin-topiramat kombinasyonu, liraglutid, semaglutid ve tirzepatid) prediyabetin tip 2 diyabete ilerleme riskini azaltt eitli almalarla gsterilmitir
2002;348:93112 Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF
If over several weeks you truly arent losing, you can revisit your plan (ensure youre not eating more due to calorie creep, and maybe bump up exercise)
As secondary outcomes were exploratory in nature, reported significance values were not adjusted for multiple comparisons
In placebo-controlled trials of patients with type 1 diabetes mellitus, the risk of ketoacidosis was markedly increased in patients who received sodium glucose co-transporter 2 (SGLT2) inhibitors compared to patients who received placebo and fatal ketoacidosis has occurred with empagliflozin